AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-80
Results: 1-25/80
MEETING HIGHLIGHTS - INTERNATIONAL CONSENSUS PANEL ON THE TREATMENT OF PRIMARY BREAST-CANCER
Authors: GOLDHIRSCH A GLICK JH GELBER RD SENN HJ
Citation: A. Goldhirsch et al., MEETING HIGHLIGHTS - INTERNATIONAL CONSENSUS PANEL ON THE TREATMENT OF PRIMARY BREAST-CANCER, Journal of the National Cancer Institute, 90(21), 1998, pp. 1601-1608
RESULTS OF DANA-FARBER-CANCER-INSTITUTE-CONSORTIUM CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA PROTOCOLS
Authors: BILLETT AL GELBER RD TARBELL NJ DALTON V DONNELLY M SALLAN SE
Citation: Al. Billett et al., RESULTS OF DANA-FARBER-CANCER-INSTITUTE-CONSORTIUM CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA PROTOCOLS, International journal of pediatric hematology/oncology, 5(2-4), 1998, pp. 115-123
PROGNOSTIC IMPACT OF AMENORRHEA AFTER ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL BREAST-CANCER PATIENTS WITH AXILLARY NODE INVOLVEMENT - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI
Authors: PAGANI O ONEILL A CASTIGLIONE M GELBER RD GOLDHIRSCH A RUDENSTAM CM LINDTNER J COLLINS J CRIVELLARI D COATES A CAVALLI F THURLIMANN B SIMONCINI E FEY M PRICE K SENN HJ
Citation: O. Pagani et al., PROGNOSTIC IMPACT OF AMENORRHEA AFTER ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL BREAST-CANCER PATIENTS WITH AXILLARY NODE INVOLVEMENT - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI, European journal of cancer, 34(5), 1998, pp. 632-640
THE PREDICTION OF RESPONSE TO CHEMOTHERAPY IN INVASIVE BREAST-CARCINOMA BY DETERMINATION OF HISTOLOGICAL GRADE
Authors: PINDER SE MURRAY S ELLIS IO TRIHIA H ELSTON CW GELBER RD GOLDHIRSCH A LINDTNER J CORTESFUNES H SIMONCINI E BYRNE MJ GOLOUH R RUDENSTAM CM CASTIGLIONEGERTSCH M
Citation: Se. Pinder et al., THE PREDICTION OF RESPONSE TO CHEMOTHERAPY IN INVASIVE BREAST-CARCINOMA BY DETERMINATION OF HISTOLOGICAL GRADE, European journal of cancer, 34, 1998, pp. 513-513
DOSE-RESPONSE EFFECT OF ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL (CMF) IN NODE-POSITIVE BREAST-CANCER
Authors: COLLEONI M PRICE K CASTIGLIONEGERTSCH M GOLDHIRSCH A COATES A LINDTNER J COLLINS J GELBER RD THURLIMANN B RUDENSTAM CM
Citation: M. Colleoni et al., DOSE-RESPONSE EFFECT OF ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL (CMF) IN NODE-POSITIVE BREAST-CANCER, European journal of cancer, 34(11), 1998, pp. 1693-1700
QUALITY-OF-LIFE ASSESSMENT IN THE ADJUVANT SETTING - IS IT RELEVANT
Authors: GELBER RD GELBER S BONETTI M GOLDHIRSCH A
Citation: Rd. Gelber et al., QUALITY-OF-LIFE ASSESSMENT IN THE ADJUVANT SETTING - IS IT RELEVANT, European journal of cancer, 34, 1998, pp. 37-37
NEW TREATMENTS FOR BREAST-CANCER - BREAKTHROUGHS FOR PATIENT-CARE OR JUST STEPS IN THE RIGHT DIRECTION
Authors: GOLDHIRSCH A COATES AS CASTIGLIONEGERTSCH M GELBER RD
Citation: A. Goldhirsch et al., NEW TREATMENTS FOR BREAST-CANCER - BREAKTHROUGHS FOR PATIENT-CARE OR JUST STEPS IN THE RIGHT DIRECTION, Annals of oncology, 9(9), 1998, pp. 973-976
ADDING ADJUVANT CMF CHEMOTHERAPY TO EITHER RADIOTHERAPY OR TAMOXIFEN - ARE ALL CMFS ALIKE
Authors: GOLDHIRSCH A COLLEONI M COATES AS CASTIGLIONEGERTSCH M GELBER RD
Citation: A. Goldhirsch et al., ADDING ADJUVANT CMF CHEMOTHERAPY TO EITHER RADIOTHERAPY OR TAMOXIFEN - ARE ALL CMFS ALIKE, Annals of oncology, 9(5), 1998, pp. 489-493
2ND MALIGNANCIES IN PATIENTS TREATED FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: DALTON VMK GELBER RD LI F DONNELLY MJ TARBELL NJ SALLAN SE
Citation: Vmk. Dalton et al., 2ND MALIGNANCIES IN PATIENTS TREATED FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of clinical oncology, 16(8), 1998, pp. 2848-2853
QUALITY-OF-LIFE-ADJUSTED SURVIVAL ANALYSIS OF INTERFERON-ALPHA-2B TREATMENT FOR ADVANCED FOLLICULAR LYMPHOMA - AN AID TO CLINICAL DECISION-MAKING
Authors: COLE BF SOLALCELIGNY P GELBER RD LEPAGE E GISSELBRECHT C REYES F SEBBAN C SUGANO D TENDLER C GOLDHIRSCH A
Citation: Bf. Cole et al., QUALITY-OF-LIFE-ADJUSTED SURVIVAL ANALYSIS OF INTERFERON-ALPHA-2B TREATMENT FOR ADVANCED FOLLICULAR LYMPHOMA - AN AID TO CLINICAL DECISION-MAKING, Journal of clinical oncology, 16(7), 1998, pp. 2339-2344
ADJUVANT CHEMOENDOCRINE THERAPY IN POSTMENOPAUSAL BREAST-CANCER - CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL DOSE AND SCHEDULE MAY MAKE A DIFFERENCE
Authors: GOLDHIRSCH A COATES AS COLLEONI M CASTIGLIONEGERTSCH M GELBER RD
Citation: A. Goldhirsch et al., ADJUVANT CHEMOENDOCRINE THERAPY IN POSTMENOPAUSAL BREAST-CANCER - CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL DOSE AND SCHEDULE MAY MAKE A DIFFERENCE, Journal of clinical oncology, 16(4), 1998, pp. 1358-1362
CAN THE Q-TWIST METHOD PROVIDE INFORMATION ON PATIENTS PREFERENCES WITHOUT COLLECTING PREFERENCE DATA FROM THE PATIENTS - IN REPLY
Authors: COLE BF GELBER RD GOLDHIRSCH A
Citation: Bf. Cole et al., CAN THE Q-TWIST METHOD PROVIDE INFORMATION ON PATIENTS PREFERENCES WITHOUT COLLECTING PREFERENCE DATA FROM THE PATIENTS - IN REPLY, Journal of clinical oncology, 16(11), 1998, pp. 3718-3718
SURVIVAL BENEFIT IN MELANOMA
Authors: COLE BF GELBER RD KIRKWOOD JM
Citation: Bf. Cole et al., SURVIVAL BENEFIT IN MELANOMA, Journal of clinical oncology, 16(1), 1998, pp. 388-389
WORKSHOP ON MISSING DATA IN QUALITY-OF-LIFE RESEARCH IN CANCER CLINICAL-TRIALS - PRACTICAL AND METHODOLOGICAL ISSUES - PREFACE
Authors: BERNHARD J GELBER RD HURNY C
Citation: J. Bernhard et al., WORKSHOP ON MISSING DATA IN QUALITY-OF-LIFE RESEARCH IN CANCER CLINICAL-TRIALS - PRACTICAL AND METHODOLOGICAL ISSUES - PREFACE, Statistics in medicine, 17(5-7), 1998, pp. 511-512
QUALITY-OF-LIFE ASSESSMENT IN INTERNATIONAL BREAST-CANCER STUDY-GROUP(IBCSG) TRIALS - PRACTICAL ISSUES AND FACTORS ASSOCIATED WITH MISSINGDATA
Authors: BERNHARD J PETERSON HF COATES AS GUSSET H ISLEY M HINKLE R GELBER RD CASTIGLIONEGERTSCH M HURNY C
Citation: J. Bernhard et al., QUALITY-OF-LIFE ASSESSMENT IN INTERNATIONAL BREAST-CANCER STUDY-GROUP(IBCSG) TRIALS - PRACTICAL ISSUES AND FACTORS ASSOCIATED WITH MISSINGDATA, Statistics in medicine, 17(5-7), 1998, pp. 587-601
QUALITY-ADJUSTED SURVIVAL ANALYSIS WITH REPEATED QUALITY-OF-LIFE MEASURES
Authors: GLASZIOU PP COLE BF GELBER RD HILDEN J SIMES RJ
Citation: Pp. Glasziou et al., QUALITY-ADJUSTED SURVIVAL ANALYSIS WITH REPEATED QUALITY-OF-LIFE MEASURES, Statistics in medicine, 17(11), 1998, pp. 1215-1229
SUBSETS WITHIN THE CHEMOTHERAPY OVERVIEW
Authors: COATES AS GELBER RD GOLDHIRSCH A
Citation: As. Coates et al., SUBSETS WITHIN THE CHEMOTHERAPY OVERVIEW, Lancet, 352(9142), 1998, pp. 1783-1784
POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS
Authors: ABE O ABE R ENOMOTO K KIKUCHI K KOYAMA H NOMURA Y SAKAI K SUGIMACHI K TOMINAGA T UCHINO J YOSHIDA M BENRAADT J VANDEVELDE AO VANDONGEN JA VERMORKEN JB GIOKAS G LISSAIOS B HARVEY VJ HOLDAWAY TM KAY RG MASON BH COATES A FORBES JF FOCAN C LOBELLE JP GATES GD POWELL J DURAND M MAURIAC L BARTHOLOMEUS S PICCART MJ GELMAN RS HENDERSON IC SHAPIRO CL HANCOCK AK MASOOD MB PARKER D PRICE JJ JACKSON S RAGAZ J DELOZIER T MACELESECH J HAYBITTLE JL BERRY D BROADWATER G CIRRINCIONE C MUSS H NORTON L BAUM M HOUGHTON J RILEY D DENT DM GUDGEON CA HACKING A GORDON NH DAVIS HL ROMESTAING P LEHINGUE Y OWEN JR MEIER P HOWELL A RIBEIRO GC SWINDELL R ALBANO J DEOLIVEIRA CF GERVASIO H GORDILHO J CARSTENSEN B PALSHOF T JOHANSEN H KORZENIOWSKI S SKOLYSZEWSKI J PORTNOJ SM ANDERSEN KW AXELSSON CK BLICHERTTOFT M MOURIDSEN HT OVERGAARD M ROSE C CORCORAN N TRAMPISCH HJ COMIS RL DAVIDSON NE GRAY R ROBERT N TORMEY DC WOOD W CHETTY U FORREST P JACK W ROSSBACH J SYLVESTER RJ VANDEVELDE CJH CUNNINGHAM MP BONNETERRE J FUMOLEAU P NAMER M BASTERT G RAUSCHECKER H SAUER R SAUERBREI W SCHAUER A SCHUMACHER M DESCHRYVER A BELFIGLIO M MARI E NICOLUCCI A SCORPIGLIONE N YOSEF HMA MCARDLE CS SMITH DC LARA PC BOCCARDO F RUBAGOTTI A ERAZO A MEDINA JY IZUO M MORISHITA Y BENTLEY A DORAN Z FENTIMAN IS HAYWARD JL RUBENS RD KAUFMANN M JONAT W SCHEURLEN H VONFOURNIER D FOUNTZILAS G KLAFSTROM P BLOMQVIST C CUZICK J MARGREITER R CASTIGLIONE M CAVILLI F COLLINS J FORBES J GELBER RD GOLDHIRSCH A LINDTNER J PRICE KN RUDENSTAM CM SENN HJ BLISS JM CHILVERS CED COOMBES RC MARTY M BOROVIK R BRUFMAN G HAYAT H ROBINSON E WIGLER N PANNUTI F TAKASHIMA S YASUTOMI T SONOO H YAMASHITA J OGAWA M WELVAART K HUPPERETS PSGJ BONTE J TENGRUP I TENNVALLNITTBY L MARTIN P ROMAIN S INGLE JN SUMAN VJ BUZDAR AU SMITH T HAKES T WITTES R DELAHUERTA R SAINZ MG BONADONNA G DELVECCHIO M VALAGUSSA P VERONESI U DUBOIS JB BIANCO AR LIPPMAN ME PIERCE LJ SIMON R STEINBERG SM MYLES JD PATER JL PRITCHARD KI ANDERSON S BROWN A BRYANT J COSTANTINO J DIGNAM J FISHER B REDMOND C WIEAND S WOLMARK N JACKSON IM PALMER MK BENGTSSON NO LARSSON LG LYTHGOE JP KISSIN M HANNISDAL E VARHAUG JE NISSENMEYER R BLAMEY RW MITCHELL AK ROBERTSON JFR UEO H MATHE G MISSET JL ABUZAHRA HT CLARKE EA MCLAUGHLIN JR CLARK RM LEVINE M MORIMOTO K SAWA K TAKATSUKA Y GUNDERSEN S HAUERJENSEN M HOST H CROSSLEY E HARRIS A BEIGHTON A CLARKE M COLLINS R DAVIES C EVANS V GODWIN J GREAVES E HARWOOD C JACKSON D JAMES S LAU E MEAD G NAUGHTEN A PETO R TOOTH A RAMBERT P ASSELAIN B SALMON RJ VILCOQ JR ARRIAGADA R HILL C LAPLANCHE A LE MG SPIELMANN M COCCONI G DIBLASIO B CATALANO R CREECH RH BROCKSCHMIDT J COOPER MR ANDRYSEK O BARKMANOVA J FALKSON CI ABRAHAM M KLIJN JGM TREURNIETDONKER AD VANPUTTEN WLJ EASTON D POWLES TJ GAZET JC SEMIGLAZOV V DESHPANDE N DIMARTINO L DOUGLAS P LINDTNER A NOTTER G BRYANT AJS EWING GH KRUSHENKOSLOSKI JL GEORGE WD GOULD A STEWART HJ STRONER P MOLLER TR RYDEN S CARSTENSEN J HATSCHEK T SODERBERG M CARPENTER JT ALBAIN K CROWLEY J GREEN S MARTINO S OSBORNE CK RAVDIN PM RUTQVIST LE WALLGREN A HOLM LE THURLIMANN B BRENNER H HERCBERGS A YOSHIMOTO M DEBOER G PATERSON AHG MEAKIN JW PANZARELLA T NAJA A BAHI J REID M SPITTLE M SENANAYAKE F BERGH J HOLMBERG L SEVELDA P ZIELINSKY CC GNANT M JAKESZ R BUCHANAN RB CROSS M DUNN JA GILLESPIE WM KELLY K MORRISON JM LITTON A CHLEBOWSKI RT BEZWODA WR CAFFIER H
Citation: O. Abe et al., POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS, Lancet, 352(9132), 1998, pp. 930-942
RADIOTHERAPY AND CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER
Authors: GOLDHIRSCH A COATES AS COLLEONI M GELBER RD
Citation: A. Goldhirsch et al., RADIOTHERAPY AND CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER, The New England journal of medicine, 338(5), 1998, pp. 330-331
THE IMPORTANCE OF THE HISTOLOGIC GRADE OF INVASIVE BREAST-CARCINOMA AND RESPONSE TO CHEMOTHERAPY
Authors: PINDER SE MURRAY S ELLIS IO TRIHIA H ELSTON GW GELBER RD GOLDHIRSCH A LINDTNER J CORTESFUNES H SIMONCINI E BYRNE MJ GOLOUH R RUDENSTAM CM CASTIGLIONEGERTSCH M GUSTERSON BA
Citation: Se. Pinder et al., THE IMPORTANCE OF THE HISTOLOGIC GRADE OF INVASIVE BREAST-CARCINOMA AND RESPONSE TO CHEMOTHERAPY, Cancer, 83(8), 1998, pp. 1529-1539
FACTORS AFFECTING BASE-LINE QUALITY-OF-LIFE IN 2 INTERNATIONAL ADJUVANT BREAST-CANCER TRIALS
Authors: BERNHARD J HURNY C COATES AS PETERSON HF CASTIGLIONEGERTSCH M GELBER RD GALLIGIONI E MARINI G THURLIMANN B FORBES JF GOLDHIRSCH A SENN HJ RUDENSTAM CM
Citation: J. Bernhard et al., FACTORS AFFECTING BASE-LINE QUALITY-OF-LIFE IN 2 INTERNATIONAL ADJUVANT BREAST-CANCER TRIALS, British Journal of Cancer, 78(5), 1998, pp. 686-693
QUALITY-OF-LIFE ASSESSMENT IN PATIENTS RECEIVING ADJUVANT THERAPY FORBREAST-CANCER
Authors: BERNHARD J HURNY C PETERSON HF GELBER RD CASTIGLIONEGERTSCH M COATES AS
Citation: J. Bernhard et al., QUALITY-OF-LIFE ASSESSMENT IN PATIENTS RECEIVING ADJUVANT THERAPY FORBREAST-CANCER, Quality of life research, 6(7-8), 1997, pp. 36-36
RETREATING RECURRENT BREAST-CANCER WITH THE SAME CMF-CONTAINING REGIMEN USED AS ADJUVANT THERAPY
Authors: CASTIGLIONEGERTSCH M TATTERSALL M HACKING A GOLDHIRSCH A GUDGEON A GELBER RD LINDTNER J COATES A COLLINS J ISLEY M SENN HJ RUDENSTAM CM
Citation: M. Castiglionegertsch et al., RETREATING RECURRENT BREAST-CANCER WITH THE SAME CMF-CONTAINING REGIMEN USED AS ADJUVANT THERAPY, European journal of cancer, 33(14), 1997, pp. 2321-2325
QUALITY-OF-LIFE ASSESSMENT IN PATIENTS RECEIVING ADJUVANT THERAPY FORBREAST-CANCER - THE IBCSG APPROACH
Authors: BERNHARD J HURNY C COATES AS PETERSON HF CASTIGLIONEGERTSCH M GELBER RD GOLDHIRSCH A SENN HJ RUDENSTAM CM
Citation: J. Bernhard et al., QUALITY-OF-LIFE ASSESSMENT IN PATIENTS RECEIVING ADJUVANT THERAPY FORBREAST-CANCER - THE IBCSG APPROACH, Annals of oncology, 8(9), 1997, pp. 825-835
MENSTRUAL-CYCLE AND TIMING OF BREAST SURGERY IN PREMENOPAUSAL NODE-POSITIVE BREAST-CANCER - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI
Authors: GOLDHIRSCH A GELBER RD CASTIGLIONE M ONEILL A THURLIMANN B RUDENSTAM CM LINDTNER J COLLINS J FORBES J CRIVELLARI D COATES A CAVALLI F SIMONCINI E FEY MF PAGANI O PRICE K SENN HJ
Citation: A. Goldhirsch et al., MENSTRUAL-CYCLE AND TIMING OF BREAST SURGERY IN PREMENOPAUSAL NODE-POSITIVE BREAST-CANCER - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI, Annals of oncology, 8(8), 1997, pp. 751-756
Risultati: 1-25 | 26-50 | 51-75 | 76-80